# Amgen net income entity: /record/amgen.md predicate: net_income page: /record/amgen/net_income as_of: 2026-11-09 cite: AsOf. "Amgen quarterly net income: 3,864,000,000 United States dollar", as of 2026-09-30. Claim clm_92C83000279C, https://asof.is/claim/clm_92C83000279C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm. As of November 9, 2026, the latest net income figure on the AsOf record for Amgen is $3.86 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). Amgen's latest full-year net income is $7.71 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 19 claims on Amgen's net income, 1 open and 18 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest net income The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_net_income claim, kept apart from the full-year series. - [Amgen](/record/amgen.md) | quarterly_net_income | 3,864,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_92C83000279C](/claim/clm_92C83000279C.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm ## Latest full-year net income What the record asserts on 2026-11-09. - [Amgen](/record/amgen.md) | net_income | 7,711,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_70EECF48CD48](/claim/clm_70EECF48CD48.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/0000318154-26-000010-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Amgen](/record/amgen.md) | net_income | 3,078,000,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_4826D0123EC0](/claim/clm_4826D0123EC0.md) | [clm_BBC1534096ED](/claim/clm_BBC1534096ED.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000119312510044311/0001193125-10-044311-index.htm - [Amgen](/record/amgen.md) | net_income | 4,052,000,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_78DDCE0217FE](/claim/clm_78DDCE0217FE.md) | [clm_4826D0123EC0](/claim/clm_4826D0123EC0.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000119312510044311/0001193125-10-044311-index.htm - [Amgen](/record/amgen.md) | net_income | 4,605,000,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_A36EA59B9520](/claim/clm_A36EA59B9520.md) | [clm_78DDCE0217FE](/claim/clm_78DDCE0217FE.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000119312510044311/0001193125-10-044311-index.htm - [Amgen](/record/amgen.md) | net_income | 4,627,000,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_77675AD86D11](/claim/clm_77675AD86D11.md) | [clm_A36EA59B9520](/claim/clm_A36EA59B9520.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000095012311018800/0000950123-11-018800-index.htm - [Amgen](/record/amgen.md) | net_income | 3,683,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_84C2CE669D18](/claim/clm_84C2CE669D18.md) | [clm_77675AD86D11](/claim/clm_77675AD86D11.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000119312512086670/0001193125-12-086670-index.htm - [Amgen](/record/amgen.md) | net_income | 4,345,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_7D7780676598](/claim/clm_7D7780676598.md) | [clm_84C2CE669D18](/claim/clm_84C2CE669D18.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000144530513000364/0001445305-13-000364-index.htm - [Amgen](/record/amgen.md) | net_income | 5,081,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_071C52720059](/claim/clm_071C52720059.md) | [clm_7D7780676598](/claim/clm_7D7780676598.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815414000004/0000318154-14-000004-index.htm - [Amgen](/record/amgen.md) | net_income | 5,158,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_797A8E0010E4](/claim/clm_797A8E0010E4.md) | [clm_071C52720059](/claim/clm_071C52720059.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815415000005/0000318154-15-000005-index.htm - [Amgen](/record/amgen.md) | net_income | 6,939,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_A5BF59D89483](/claim/clm_A5BF59D89483.md) | [clm_797A8E0010E4](/claim/clm_797A8E0010E4.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815416000031/0000318154-16-000031-index.htm - [Amgen](/record/amgen.md) | net_income | 7,722,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_2C7BDDED6E27](/claim/clm_2C7BDDED6E27.md) | [clm_A5BF59D89483](/claim/clm_A5BF59D89483.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815417000004/0000318154-17-000004-index.htm - [Amgen](/record/amgen.md) | net_income | 1,979,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_7F963F7A3BF5](/claim/clm_7F963F7A3BF5.md) | [clm_2C7BDDED6E27](/claim/clm_2C7BDDED6E27.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815418000004/0000318154-18-000004-index.htm - [Amgen](/record/amgen.md) | net_income | 8,394,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_43A49B7648F8](/claim/clm_43A49B7648F8.md) | [clm_7F963F7A3BF5](/claim/clm_7F963F7A3BF5.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815419000008/0000318154-19-000008-index.htm - [Amgen](/record/amgen.md) | net_income | 7,842,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_673D61CD1F43](/claim/clm_673D61CD1F43.md) | [clm_43A49B7648F8](/claim/clm_43A49B7648F8.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815420000017/0000318154-20-000017-index.htm - [Amgen](/record/amgen.md) | net_income | 7,264,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_BF2E5D6BD634](/claim/clm_BF2E5D6BD634.md) | [clm_673D61CD1F43](/claim/clm_673D61CD1F43.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815421000010/0000318154-21-000010-index.htm - [Amgen](/record/amgen.md) | net_income | 5,893,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_C644E157DE79](/claim/clm_C644E157DE79.md) | [clm_BF2E5D6BD634](/claim/clm_BF2E5D6BD634.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815422000010/0000318154-22-000010-index.htm - [Amgen](/record/amgen.md) | net_income | 6,552,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_566AA4B9BFA3](/claim/clm_566AA4B9BFA3.md) | [clm_C644E157DE79](/claim/clm_C644E157DE79.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815423000017/0000318154-23-000017-index.htm - [Amgen](/record/amgen.md) | net_income | 6,717,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_ED179BBDEBC9](/claim/clm_ED179BBDEBC9.md) | [clm_566AA4B9BFA3](/claim/clm_566AA4B9BFA3.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/0000318154-24-000011-index.htm - [Amgen](/record/amgen.md) | net_income | 4,090,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_70EECF48CD48](/claim/clm_70EECF48CD48.md) | [clm_ED179BBDEBC9](/claim/clm_ED179BBDEBC9.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000010/0000318154-25-000010-index.htm - [Amgen](/record/amgen.md) | net_income | 7,711,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_70EECF48CD48](/claim/clm_70EECF48CD48.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/0000318154-26-000010-index.htm ## What replaced what - $3.08 billion (2007-12-31 to 2008-12-31, [clm_BBC1534096ED](/claim/clm_BBC1534096ED.md)) was replaced by $4.05 billion from 2008-12-31 ([clm_4826D0123EC0](/claim/clm_4826D0123EC0.md)) - $4.05 billion (2008-12-31 to 2009-12-31, [clm_4826D0123EC0](/claim/clm_4826D0123EC0.md)) was replaced by $4.61 billion from 2009-12-31 ([clm_78DDCE0217FE](/claim/clm_78DDCE0217FE.md)) - $4.61 billion (2009-12-31 to 2010-12-31, [clm_78DDCE0217FE](/claim/clm_78DDCE0217FE.md)) was replaced by $4.63 billion from 2010-12-31 ([clm_A36EA59B9520](/claim/clm_A36EA59B9520.md)) - $4.63 billion (2010-12-31 to 2011-12-31, [clm_A36EA59B9520](/claim/clm_A36EA59B9520.md)) was replaced by $3.68 billion from 2011-12-31 ([clm_77675AD86D11](/claim/clm_77675AD86D11.md)) - $3.68 billion (2011-12-31 to 2012-12-31, [clm_77675AD86D11](/claim/clm_77675AD86D11.md)) was replaced by $4.35 billion from 2012-12-31 ([clm_84C2CE669D18](/claim/clm_84C2CE669D18.md)) - $4.35 billion (2012-12-31 to 2013-12-31, [clm_84C2CE669D18](/claim/clm_84C2CE669D18.md)) was replaced by $5.08 billion from 2013-12-31 ([clm_7D7780676598](/claim/clm_7D7780676598.md)) - $5.08 billion (2013-12-31 to 2014-12-31, [clm_7D7780676598](/claim/clm_7D7780676598.md)) was replaced by $5.16 billion from 2014-12-31 ([clm_071C52720059](/claim/clm_071C52720059.md)) - $5.16 billion (2014-12-31 to 2015-12-31, [clm_071C52720059](/claim/clm_071C52720059.md)) was replaced by $6.94 billion from 2015-12-31 ([clm_797A8E0010E4](/claim/clm_797A8E0010E4.md)) - $6.94 billion (2015-12-31 to 2016-12-31, [clm_797A8E0010E4](/claim/clm_797A8E0010E4.md)) was replaced by $7.72 billion from 2016-12-31 ([clm_A5BF59D89483](/claim/clm_A5BF59D89483.md)) - $7.72 billion (2016-12-31 to 2017-12-31, [clm_A5BF59D89483](/claim/clm_A5BF59D89483.md)) was replaced by $1.98 billion from 2017-12-31 ([clm_2C7BDDED6E27](/claim/clm_2C7BDDED6E27.md)) - $1.98 billion (2017-12-31 to 2018-12-31, [clm_2C7BDDED6E27](/claim/clm_2C7BDDED6E27.md)) was replaced by $8.39 billion from 2018-12-31 ([clm_7F963F7A3BF5](/claim/clm_7F963F7A3BF5.md)) - $8.39 billion (2018-12-31 to 2019-12-31, [clm_7F963F7A3BF5](/claim/clm_7F963F7A3BF5.md)) was replaced by $7.84 billion from 2019-12-31 ([clm_43A49B7648F8](/claim/clm_43A49B7648F8.md)) - $7.84 billion (2019-12-31 to 2020-12-31, [clm_43A49B7648F8](/claim/clm_43A49B7648F8.md)) was replaced by $7.26 billion from 2020-12-31 ([clm_673D61CD1F43](/claim/clm_673D61CD1F43.md)) - $7.26 billion (2020-12-31 to 2021-12-31, [clm_673D61CD1F43](/claim/clm_673D61CD1F43.md)) was replaced by $5.89 billion from 2021-12-31 ([clm_BF2E5D6BD634](/claim/clm_BF2E5D6BD634.md)) - $5.89 billion (2021-12-31 to 2022-12-31, [clm_BF2E5D6BD634](/claim/clm_BF2E5D6BD634.md)) was replaced by $6.55 billion from 2022-12-31 ([clm_C644E157DE79](/claim/clm_C644E157DE79.md)) - $6.55 billion (2022-12-31 to 2023-12-31, [clm_C644E157DE79](/claim/clm_C644E157DE79.md)) was replaced by $6.72 billion from 2023-12-31 ([clm_566AA4B9BFA3](/claim/clm_566AA4B9BFA3.md)) - $6.72 billion (2023-12-31 to 2024-12-31, [clm_566AA4B9BFA3](/claim/clm_566AA4B9BFA3.md)) was replaced by $4.09 billion from 2024-12-31 ([clm_ED179BBDEBC9](/claim/clm_ED179BBDEBC9.md)) - $4.09 billion (2024-12-31 to 2025-12-31, [clm_ED179BBDEBC9](/claim/clm_ED179BBDEBC9.md)) was replaced by $7.71 billion from 2025-12-31 ([clm_70EECF48CD48](/claim/clm_70EECF48CD48.md)) ## Questions this record answers ### What is Amgen's current net income? The latest figure on the record is $3.86 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $7.71 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026. ### What was Amgen's net income for the quarter ended September 30, 2026? $3.86 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did Amgen's net income last change? The latest value on the record is $7.71 billion, dated December 31, 2025; before it the record holds $4.09 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was Amgen's net income before $7.71 billion? $4.09 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/amgen/net_income (markdown: /record/amgen/net_income.md) - Entity twin: /record/amgen.md ยท timeline: /timelines/amgen.md - Every company's net income: /facts/net_income.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.